Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Condition:   Uveal Melanoma Interventions:   Drug: PAC-1;   Drug: Entrectinib Sponsors:   Arkadiusz Z. Dudek, MD;   HealthPartners Regions Cancer Care and Frauenshuh Cancer Care Centers;   Vanquish Oncology, Inc.;   Genentech, Inc.;   Midwest Melanoma Partnership Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials